Test Price
2,800 AED✅ Home Collection Available
SGCA Gene Limb‑Girdle Muscular Dystrophy Type 2D Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS workflow (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM across all Emirates.
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance to interpret your SGCA gene results with a DHA-licensed Consultant Medical Genetics specialist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The SGCA Gene Genetic Test detects pathogenic variants in SGCA causing autosomal recessive limb‑girdle muscular dystrophy type 2D (LGMD2D). It enables precise diagnosis, family screening, and informed neuromuscular management with a turnaround time of 3‑4 weeks. Next‑Generation Sequencing (NGS) provides full gene coverage with 99.9% sensitivity for SNVs, indels, and copy number changes, outperforming traditional Sanger sequencing.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Technology | Next‑Generation Sequencing (NGS) – full gene coverage | Single‑gene Sanger sequencing |
| Sensitivity | 99.9% detection of SNVs, indels, and copy number changes | Limited to targeted exons; may miss large rearrangements |
| Turnaround Time | 3‑4 Weeks | 4‑6 Weeks |
| Genetic Counselling | Included pre‑ and post‑test session | Often optional or external |
Physician Insight & Safety Protocols
“A positive SGCA result is not a final verdict but a roadmap to precise multidisciplinary care. Every result must be correlated with your clinical presentation by a Consultant Medical Geneticist experienced in LGMD2D. Our role is to guide you from genetic uncertainty toward an active and informed management plan.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
⚠ Medication Advisory
Do not stop, adjust, or alter any prescribed medication—including corticosteroids, cardiac therapies, or respiratory support—without explicit guidance from your treating neurologist. Abrupt changes may accelerate muscle weakness or compromise cardiac function.
Exclusion Criteria & ER Red Flags
Exclusion Criteria & ER Red Flags
- Specimen collection is contraindicated in patients with acute haemodynamic instability or active respiratory compromise.
- This genetic test is not suitable for emergency room diagnostics or acute medical triage.
- If you experience sudden respiratory distress, severe chest pain, or inability to walk, seek immediate emergency care – do not wait for test results.
- For minors under 18 years, a legal guardian must provide written consent in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What does a positive SGCA gene result mean for my muscle health?
A positive result confirms that you carry biallelic pathogenic variants in the SGCA gene, establishing a diagnosis of limb‑girdle muscular dystrophy type 2D. This finding enables targeted neuromuscular surveillance, cardiac monitoring, and genetic counselling for at‑risk family members.
2. How long does it take to receive my SGCA NGS report?
The average reporting time is 3‑4 weeks from sample receipt. High‑depth NGS coupled with expert variant interpretation under ISO 9001:2015 standards ensures both accuracy and comprehensive coverage of all clinically relevant regions.
3. Is home blood collection available across all Emirates?
Yes. Our DHA-licensed phlebotomists provide VIP Mobile Phlebotomy and temperature‑controlled cold‑chain home collection daily from 8 AM to 11 PM across Dubai, Abu Dhabi, Sharjah, and the Northern Emirates, with real‑time chain‑of‑custody tracking.
UAE Regulatory & Data Privacy Adherence
All genetic data generated by this test is processed and stored in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Results are shared only with the requesting physician and the patient with explicit consent. DNA Labs UAE operates under DHA Facility License Number 1143 and holds ISO 9001:2015 accreditation (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | SGCA Gene Limb‑Girdle Muscular Dystrophy Type 2D Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3‑4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full gene coverage with 99.9% sensitivity for SNVs, indels, and copy number variants |
| ICD-10-CM Code | G71.0, Z14.8, Z13.79 |
| LOINC Code | 95983-4 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians